Unlocking value by interrogating pharma spending â RxBenefits
Pharmacy spend is becoming a key value lever at US portfolio companies as PE firms up their focus on healthcare oversight, says RxBenefitsâ Peter Lombardi.
Copyright PEI Media
Not for publication, email or dissemination